A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures

Toxicology Letters

Volumn 105, Issue 1, 1999, Pages 47-57

  Williams, Julie M ^a   Boyd, Beth ^b   Nutikka, Anita ^b   Lingwood, Clifford A ^b   Barnett Foster, Debora E ^b   Milford, David V ^c   Taylor, C Mark ^c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Primary renal cell cultures; Protein synthesis inhibition; Verocytotoxin 1

Indexed keywords

VEROTOXIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TOXICOLOGY; VERO CELL;

ANIMALS; BACTERIAL TOXINS; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CYTOTOXINS; DNA FRAGMENTATION; EPITHELIAL CELLS; ESCHERICHIA COLI; GLOMERULAR MESANGIUM; HUMANS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; PROTEIN SYNTHESIS INHIBITORS; SHIGA-LIKE TOXIN I; VERO CELLS;

EID: 0032997077     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00383-X     Document Type: Article

References (24)

1. Arab, S., Lingwood, C.A., 1998. Intracellular targeting of the nuclear envelope by retrograde transport determines cell hypersensitivity to verotoxin: sodium butyrate induces nuclear toxin targeting via globotriaosyl ceramide fatty acid isoform traffic. J. Cell. Physiol. (in press).
2. Boyd B., Lingwood C.A. Verotoxin receptor glycolipid in human renal tissue. Nephron. 51:1989;207-210.
3. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Chem. J. 52:1956;315-323.
4. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
5. Chatterjee S. Regulation of synthesis of lactosylceramide in normal and tumor cortical tubular cells. Biochim. Biophys. Acta. 1167:1993;339-344.
6. Finter N.B. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. Gen. Virol. 5:1969;419-427.
7. Hughes A.K., Stricklett P.K., Kohan D.E. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int. 54:1998;426-437.
8. Inward C.D., Williams J., Chant I., Crocker J., Milford D.V., Rose P.E., Taylor C.M. Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. 30:1995;213-218.
9. Karpman D., Andreasson A., Thysell H., Kaplan B.S., Svanborg C. Cytokines in childhood hemolytic uremic syndrome and thrombocytopenic purpura. Pediatr. Nephrol. 9:1995;694-699.
10. Kasai K., Galton J., Terasaki P.I., Wakisaka A., Kawahara M., Root T., Hakomori S-I. Tissue distribution of the Pk antigen as determined by a monoclonal antibody. J. Immunogenetics. 12:1985;213-220.
11. Khine A.A., Lingwood C.A. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin) 1: chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J. Cell. Physiol. 161:1994;319-332.
12. Lingwood C.A. Verotoxin-binding in human renal sections. Nephron. 66:1994;21-28.
13. Lingwood C.A. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4:1996;147-153.
14. Mahan J.D., van Setten P.A., McAllister C., van den Heuvel L.P.W.J., Monnens L.A.H. The human mesangial cell is a target for Verotoxin-1 (VT-1) of the Hemolytic Uremic Syndrome. J. Am. Soc. Nephrol. 5:1994;835.
15. Mahan J.D., Turman M.A., McAllister C., Karmali M. Verocytotoxin-1 (VT-1) induces apoptosis in human glomerular capillary endothelial cells (GCEC) and mesangial cells (MC) in vitro. Pediatr. Res. 39:1996;2168.
16. Mahan J.D., Turman M.A., McAllister C., Karmali M. Toxicity of the hemolytic uremic syndrome (HUS) verocytotoxin-1 (VT-1) for human cortical epithelial cells (PTEC). Pediatr. Res. 39:1996;2169.
17. k, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors. Int. J. Cancer. 48:1991;848-854.
18. Robinson L.A., Hurley R.M., Lingwood C., Matsell D.G. Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Pediatr. Nephrol. 9:1995;700-704.
19. Shayman J.A., Radin N.S. Structure and function of renal glycosphingolipids. Am. J. Physiol. 260:1991;291-302.
20. Simon M., Utomo A.R., Choudhury G.G., Abboud H.E. Effects of Shiga-like toxin (SLT-1) on human mesangial cells. J. Am. Soc. Nephrol. 7:1996;1746.
21. Strasberg P., Grey A., Warren I., Skomorowski M.A. Simultaneous fractionation of 4 placental neutral glycosphingolipids with a continuous gradient. Lipid Res. 30:1989;121-127.
22. Tesh, V.L., Samuel, J.E., Burris J.A., Owens, J.W., Taylor, F.B., Siegler, R.L., 1994. Quantitation and localisation of shiga toxin/shiga-like toxin-binding glycolipid receptors in human and baboon tissues. In: Karmali, M.A., Goglio, A.G. (Eds.), Recent Advances in Verocytotoxin-Producing Escherichia coli Infections. Elsevier, Amsterdam, pp. 189-192.
23. +) associated HUS patient. 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-producing Escherichia coli Infections, Baltimore 1997.
24. van Setten P.A., van Hinsberg V.W.M., van den Heuval L.P., van der Velden T.J., van de Kar N.C., Monnens L.A.H. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without effecting viability. Evidence for two distinct pathways. Kidney Int. 52:1997;573.